Literature DB >> 8441343

Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts.

A Poulos1, S Usher, B C Paton.   

Abstract

The incorporation of [2-14C]acetate into the lipids of normal and peroxisome-deficient (Zellweger's syndrome) skin fibroblasts was examined. Most of the label was incorporated into triacylglycerol fatty acids in normal as well as Zellweger's syndrome cells. Triacylglycerols and cholesteryl esters in Zellweger's syndrome cells contained increased levels of labelled saturated and monounsaturated very long-chain fatty acids (VLCFA, that is fatty acids with more than 22 carbon atoms), in particular hexacosanoic (26:0) and hexacosaenoic (26:1) acids. As traces of labelled VLCFA with up to 32 carbon atoms were detected in triacylglycerols even in control cells it is probable that these fatty acids are formed naturally during the elongation process. Our data suggest that peroxisomes are involved in the chain shortening of the saturated and monounsaturated VLCFA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441343     DOI: 10.1007/bf02535771

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.

Authors:  A Poulos; H Singh; B Paton; P Sharp; N Derwas
Journal:  Clin Genet       Date:  1986-05       Impact factor: 4.438

2.  Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.

Authors:  J M Street; H Singh; A Poulos
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

3.  Metabolism of saturated and polyunsaturated fatty acids by normal and Zellweger syndrome skin fibroblasts.

Authors:  J M Street; D W Johnson; H Singh; A Poulos
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

4.  In vitro formation of bile acids from di- and trihydroxy-5 beta-cholestanoic acid in human liver peroxisomes.

Authors:  B F Kase; K Prydz; I Björkhem; J I Pedersen
Journal:  Biochim Biophys Acta       Date:  1986-06-11

5.  A comparative study of stearic and lignoceric acid oxidation by human skin fibroblasts.

Authors:  H Singh; A Poulos
Journal:  Arch Biochem Biophys       Date:  1986-10       Impact factor: 4.013

6.  Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.

Authors:  L Schepers; M Casteels; J Vamecq; G Parmentier; P P Van Veldhoven; G P Mannaerts
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

7.  Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age.

Authors:  L Svennerholm; S Ställberg-Stenhagen
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

8.  The occurrence of polyenoic fatty acids with greater than 22 carbon atoms in mammalian spermatozoa.

Authors:  A Poulos; P Sharp; D Johnson; I White; A Fellenberg
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

9.  Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).

Authors:  S Tsuji; T Sano; T Ariga; T Miyatake
Journal:  J Biochem       Date:  1981-10       Impact factor: 3.387

10.  Localization of enzymes involved in glycero-ether bond formation in rat liver.

Authors:  D Hardeman; H van den Bosch
Journal:  Biochim Biophys Acta       Date:  1991-02-05
View more
  2 in total

1.  Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.

Authors:  Masashi Morita; Misato Kawamichi; Yusuke Shimura; Kosuke Kawaguchi; Shiro Watanabe; Tsuneo Imanaka
Journal:  Metab Brain Dis       Date:  2015-06-25       Impact factor: 3.584

Review 2.  Very long chain fatty acids in higher animals--a review.

Authors:  A Poulos
Journal:  Lipids       Date:  1995-01       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.